0001209191-21-042256.txt : 20210621
0001209191-21-042256.hdr.sgml : 20210621
20210621190429
ACCESSION NUMBER: 0001209191-21-042256
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Robert E Jr
CENTRAL INDEX KEY: 0001592280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 211032516
MAIL ADDRESS:
STREET 1: CAMBRIDGE DISCOVERY PARK
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 9787296480
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-16
0
0001679363
Morphic Holding, Inc.
MORF
0001592280
Farrell Robert E Jr
C/O MORPHIC HOLDING, INC.
35 GATEHOUSE DRIVE, A2
WALTHAM
MA
02451
0
1
0
0
SVP Finance and CAO
Common Stock
2021-06-16
4
M
0
300
4.32
A
18234
D
Common Stock
2021-06-16
4
S
0
300
65.0033
D
17934
D
Common Stock
2021-06-18
4
M
0
200
4.32
A
18134
D
Common Stock
2021-06-18
4
S
0
200
65.00
D
17934
D
Stock Option (right to buy Common Stock)
4.32
2021-06-16
4
M
0
300
0.00
D
2028-12-14
Common Stock
3000
75444
D
Stock Option (right to buy Common Stock)
4.32
2021-06-18
4
M
0
200
0.00
D
2028-12-14
Common Stock
200
75244
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.01 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Robert Farrell, Jr.
2021-06-19